A: Dr. Shina Goyal specializes in managing breast, gastrointestinal, gynecological, head and neck cancers, Sarcoma and thoracic cancers. She also treats hereditary cancers, focusing on targeted therapy and immuno-oncology. Her approach combines evidence-based medicine with personalized care plans tailored to each patient’s condition, ensuring comprehensive diagnosis, treatment, and long-term management for improved outcomes and quality of life.

Dr. Goyal offers a full range of cancer treatments, including chemotherapy, targeted therapy, immunotherapy, and precision oncology. She integrates global treatment protocols with a patient-centric approach to minimize side effects and improve treatment response. Each therapy plan is individualized, based on tumor biology, genetic profile, and patient health, ensuring safe and effective outcomes.

A: Her approach combines advanced scientific knowledge with empathy and clear communication. She emphasizes patient education, shared decision-making, and holistic management — addressing not just the disease, but also the emotional and social aspects of cancer. With her international training and extensive experience, she bridges global oncology standards with individualized Indian patient care.

Precision oncology uses molecular and genetic testing to identify mutations driving a patient’s cancer. Dr. Goyal applies this data to design highly targeted, effective treatment plans. This personalized approach improves outcomes, reduces unnecessary toxicity, and ensures therapies align with the patient’s unique cancer profile, revolutionizing modern cancer care.

Yes, Dr. Goyal offers comprehensive second-opinion consultations for patients seeking clarity on diagnosis or treatment plans. She reviews medical records, pathology reports, and test results to ensure accuracy and guide the most effective treatment pathway. Her evidence-based insights empower patients to make informed, confident decisions about their care.

A: Not all cancers respond to immunotherapy. Dr. Goyal carefully evaluates each patient’s cancer type and overall health to determine suitability. When appropriate, she uses immunotherapy to help the immune system recognize and destroy cancer cells, offering improved survival and fewer side effects compared to conventional chemotherapy.

Dr. Goyal emphasizes proactive side-effect management through pre-treatment counseling, supportive medications, and continuous monitoring. Her focus is on maintaining patients’ comfort, nutritional health, and mental well-being. With tailored drug regimens and modern supportive care, she minimizes nausea, fatigue, and infections, helping patients maintain quality of life during treatment.

Patients receive multidisciplinary support, including nutritional counseling, psychological care, physiotherapy, and rehabilitation. Dr. Goyal believes in holistic healing and collaborates with expert teams to manage every aspect of cancer care. This approach ensures patients receive not only medical treatment but also emotional and social support throughout their journey.

Dr. Shina Goyal primarily focuses on adult oncology, including breast, gastrointestinal, thoracic, and gynecologic cancers. However, she collaborates closely with pediatric oncology specialists when necessary to ensure comprehensive care. Her expertise lies in precision-based therapies and adult cancer management, ensuring safe and effective outcomes.

Patients can book appointments directly through Max Super Speciality Hospital, Dwarka, or via online consultation platforms. For convenience, teleconsultations are also available for follow-ups and second opinions. Her team assists with scheduling, document review, and care coordination to ensure a seamless experience for every patient.

Outcomes vary based on cancer type, stage, and individual response. Dr. Goyal focuses on achieving the best possible survival rates, minimal side effects, and improved quality of life. Her integration of global protocols, personalized therapy, and compassionate care ensures patients receive safe, effective, and evidence-backed treatment outcomes.